Founder and Executive Chairman Fuad El-Hibri to retire from Emergent BioSolutions effective April 1, 2022

Emergent BioSolutions Inc.

Fuad El-Hibri, founder and executive chairman, will retire effective April 1, 2022, after 23 years.
Retirement not due to any dispute with company, management, or board.
He will remain available on advisory/consulting basis on terms to be agreed.
Board expects to name new chair ahead of retirement date.
Under his leadership, Emergent generated ~$1.6B revenue in 2020 and delivered over 120M dose-equivalents of COVID-19 vaccine.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Fuad El-Hibri

Executive Chairman of the Board

EBS · Emergent BioSolutions Inc.

Effective: 2022-04-01
Filed: January 14, 2022, 6:59 PM ET

On January 13, 2022, Fuad El-Hibri, Founder and Executive Chairman of the Board of Directors (the “Board”) of Emergent BioSolutions Inc. (the “Company”), notified the Company of his retirement and resignation as an officer, director and employee of the Company, effective as of April 1, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Fuad El-Hibri departed as Executive Chairman of the Board at Emergent BioSolutions Inc..

Action: retired and resigned
Role: Executive Chairman of the Board

Exact text from the filing

On January 13, 2022, Fuad El-Hibri, Founder and Executive Chairman of the Board of Directors (the “Board”) of Emergent BioSolutions Inc. (the “Company”), notified the Company of his retirement and resignation as an officer, director and employee of the Company, effective as of April 1, 2022.

View on SEC.gov

Emergent BioSolutions Inc. filing history →

Source: SEC EDGAR

accession 0001367644-22-000006

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.